Navigation Links
Webster Lasso Circular Mapping Catheter

ProductsWebster Lasso Circular Mapping Catheter
Company Biosense Webster, a Johnson & Johnson Company
Item Webster Lasso Circular Mapping Catheter
Features 
  • Flexible, proprietary LASSO curve is easily manipulated for accurate delivery and placement--yet retains its shape for circular mapping
  • Precise electrode spacing on LASSO curve assists physicians in accurate visualization of PV potentials' exit sites
  • Deflectable tip engages various anatomical structures with ease--including the pulmonary veins and coronary sinus
  • Soft tip provides smooth introduction into guiding sheath and may reduce the risk of perforation
  • 7F catheter size fits a standard 8F guiding sheath (PREFACE or similar)
  • Braided stainless steel shaft--from handle to deflectable tip--provides excellent torqueability/stability
  • Distal electrode marker helps with visualization of catheter under fluoroscopy
  • Redel connector permits quick connection and is compatible with standard diagnostic cables
  • Description For Pulmonary Vein Mapping. The LASSO Circular Mapping Catheter from Biosense Webster is the first circular catheter capable of circumferentially mapping the myocardial sleeves around the pulmonary veins (PV). Its unique design allows the sequential assessment of PV potentials for targeted therapy to achieve pulmonary vein isolation. The circular LASSO curve with multiple, precisely spaced electrodes permits simultaneous electrogram recording of a circumferential area without repositioning the catheter. This proprietary feature allows clinicians to quickly identify PV potentials and confirm post-conduction block. The LASSO deflectable catheter is deployed into the left atrium through an 8F guiding sheath (PREFACE), and interfaces with standard EP recording equipment.
    Info Biosense Webster, a Johnson & Johnson Company
    Customer Service: (800) 729-9010
    Web site: http://www.biosensewebster.com/

    Related medicine products :

    1. Webster Ruler
    2. Webster Small Anatomy Fixed Curve Catheters
    3. Webster Supra CS Decapolar (Coronary Sinus Fixed Curve Catheters)
    4. Webster Small Anatomy Deflectable Catheters
    5. Webster Coronary Sinus Deflectable Catheters
    6. Webster Quadripolar Standard Deflectable Catheters
    7. Webster Octapolar Standard Deflectable Catheters
    8. Webster Quadrapolar Standard Deflectable Catheters
    9. Webster Decapolar Standard Deflectable Catheters
    10. Webster Decapolar Coronary Sinus Deflectable Catheters
    11. Webster Parahisian octapolar catheter
    ... The hands play an important part ... traumatic impairments and rheumatic changes can cause ... developing of the finger-joint prostheses was to ... reproduce the natural function as nearly possible.,The ...
    ... hands play an important part in our ... and rheumatic changes can cause severe handicaps. ... the finger-joint prostheses was to produce a ... natural function as nearly possible.,The cementless RM ...
    ... Profile Leg Holder provides precise control of the ... and maximum exposure of the proximal thigh during ... Holder can be used on both right and ... heights.,The Low Profile Leg Holder can be used ...
    ... is ideal for trauma, foot and ankle ... products ,True/Lok External Fixation components are designed ... assembly and the complexity of intra-operative and ... preassembled distractors and hinges eliminate the need ...
    Medicine Products:
    (Date:4/26/2017)... ... 26, 2017 , ... New SUPRO® XT55 Isolated Soy ... by helping beverage manufacturers more effectively manage protein costs. “Soy protein has always ... well as more stable pricing over time. Now it’s even more relevant as ...
    (Date:4/25/2017)... ... April 25, 2017 , ... Bellus ... that’s the first in a new class of photodynamic cosmetics (PDC). , Allumera® ... skin, visibly reduce outward signs of aging, and minimize the appearance of pores ...
    (Date:4/25/2017)... ... April 25, 2017 , ... ... to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, ... cells) Phase I/II HOPE clinical trial in Duchenne announced today. , Coalition ...
    (Date:4/25/2017)... ... April 25, 2017 , ... A recent ... test score performance for the 2015-16 school year across Wisconsin’s public schools, charter ... it highlights important patterns in student test score performance, the report’s limited analyses ...
    (Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
    Breaking Medicine News(10 mins):
    (Date:4/20/2017)... 2017  Vivify Health, the pioneer and market leader ... a very significant patent for the advancement of healthcare ... via digital health.  This landmark patent provides the company ... secures Vivify,s position as the leader in remote care.  ... first company to apply consumer mobile devices, wireless biometrics, ...
    (Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
    (Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
    Breaking Medicine Technology: